| Announce Date | 01/29/2026 |
| EPS Normalized Actual | $6.2 (Beat by $2.58) |
| EPS GAAP Actual | $6.2 (Beat by $2.58) |
| Revenue Actual | $3.025B |
| Revenue Surprise | Beat by $3025M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Jun 2030 | 13.5354 | 46.59 | 11.72345 | 15.12434 | 1 |
| Jun 2030 | 13.5354 | 46.59 | 11.8558 | 15.27611 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ1 2026 (Jan 2026) | 5.46 | 5.46 | 3.025B | 43.97% | 3025M |
| FQ4 2025 (Oct 2025) | 0 | 0 | 2.308B | 18.72% | 2308M |
| FQ1 2025 (Mar 2025) | -13.33 | -13.33 | 1.695B | -0.59% | 1695M |
| FQ2 2025 (Jun 2025) | -0.16 | -0.16 | 1.901B | 100% | 1901M |
| FQ4 2023 (Dec 2023) | -1.49 | -1.49 | 1.665B | 100% | 1665M |
| FQ3 2023 (Sep 2023) | 0 | 0 | 1.533B | 100% | 1533M |
| FQ1 2024 (Mar 2024) | 0.19 | 0.19 | 1.705B | 100% | 1705M |
| FQ3 2024 (Sep 2024) | 1.47 | 1.47 | 1.883B | 18.59% | 1883M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 0.85 | -- | 0.78273 | 0.89364 | 3 |
| FQ3 2028 (Jul 2028) | 13.52 | -- | 10.05838 | 17.00966 | 3 |
| FQ2 2028 (Apr 2028) | 14.955 | -- | 11.12597 | 18.81505 | 3 |
| FQ1 2028 (Jan 2028) | 21.675 | -- | 16.1254 | 27.26955 | 3 |
| FQ4 2027 (Dec 2027) | 1.41 | -- | 1.26865 | 1.51504 | 5 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2028 (Dec 2028) | 1.97B | -- | 1.85B | 2.04B | 3 |
| FQ3 2028 (Jul 2028) | 5.53B | -- | 4.44B | 6.62B | 5 |
| FQ2 2028 (Apr 2028) | 5.7B | -- | 4.57B | 6.83B | 3 |
| FQ1 2028 (Jan 2028) | 6.71B | -- | 5.39B | 8.04B | 5 |
| FQ4 2027 (Dec 2027) | 2.15B | -- | 1.98B | 2.27B | 8 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
3
EPS # of Misses
3
EPS # of in-lines
2
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2026 (Jan 2026) | 5.46 | 5.46 | 100% | |
| FQ4 2025 (Oct 2025) | 0 | 0 | NAN% | |
| FQ1 2025 (Mar 2025) | -13.33 | -13.33 | 100% | |
| FQ2 2025 (Jun 2025) | -0.16 | -0.16 | 100% | |
| FQ4 2023 (Dec 2023) | -1.49 | -1.49 | 100% | |
| FQ3 2023 (Sep 2023) | 0 | 0 | NAN% | |
| FQ1 2024 (Mar 2024) | 0.19 | 0.19 | 100% | |
| FQ3 2024 (Sep 2024) | 1.47 | 1.47 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ1 2026 (Jan 2026) | $0B | $3.03B | $3025M | 100% |
| FQ4 2025 (Oct 2025) | $0B | $2.31B | $2308M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $1.7B | $1695M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $1.9B | $1901M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.67B | $1665M | 100% |
| FQ3 2023 (Sep 2023) | $0B | $1.53B | $1533M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.71B | $1705M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.88B | $1883M | 100% |